Teva Pharmaceutical Industries Ltd ADR Stock
The price for the Teva Pharmaceutical Industries Ltd ADR stock decreased slightly today. Compared to yesterday there is a change of -€0.300 (-0.980%).
With 23 Buy predictions and not a single Sell prediction Teva Pharmaceutical Industries Ltd ADR is an absolute favorite of our community.
With a target price of 34 € there is a slightly positive potential of 11.84% for Teva Pharmaceutical Industries Ltd ADR compared to the current price of 30.4 €.
Our community identified positive and negative aspects for Teva Pharmaceutical Industries Ltd ADR stock for the coming years. 4 users see the criterium "Worthwhile Investment for the next years" as a plus for the Teva Pharmaceutical Industries Ltd ADR stock. On the other hand our users think that "Conscious of the environment" could be a problem in the future.
Pros and Cons of Teva Pharmaceutical Industries Ltd ADR in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Teva Pharmaceutical Industries Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | -0.980% | 12.177% | 2.357% | 124.354% | 13.011% | 297.906% | 273.464% |
| Bayer AG ADR | 1.720% | 5.357% | -3.279% | 72.263% | 34.091% | -10.606% | -4.839% |
| Novartis AG | -1.120% | -0.383% | -1.168% | 36.150% | 14.537% | 69.200% | 69.200% |
| Novartis AG ADR | -0.720% | -0.730% | -1.449% | 36.546% | 14.768% | 42.558% | 74.359% |
Comments
Teva Pharmaceutical Industries (TEVA) had its price target raised by Piper Sandler from $42.00 to $44.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (TEVA) had its price target raised by Barclays PLC from $38.00 to $40.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat
Teva Pharmaceutical Industries (TEVA) had its price target raised by UBS Group AG from $36.00 to $42.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TEVA provided by MarketBeat